BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23117435)

  • 1. 4-(1H-Pyrazol-1-yl) benzenesulfonamide derivatives: identifying new active antileishmanial structures for use against a neglected disease.
    Marra RK; Bernardino AM; Proux TA; Charret KS; Lira ML; Castro HC; Souza AM; Oliveira CD; Borges JC; Rodrigues CR; Canto-Cavalheiro MM; Leon LL; Amaral VF
    Molecules; 2012 Nov; 17(11):12961-73. PubMed ID: 23117435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation against Leishmania amazonensis of a series of alkyl-substituted benzophenones.
    Maciel-Rezende CM; de Almeida L; Costa ÉD; Pires FR; Alves KF; Viegas C; Dias DF; Doriguetto AC; Marques MJ; dos Santos MH
    Bioorg Med Chem; 2013 Jun; 21(11):3114-9. PubMed ID: 23623672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nanoemulsions prepared with essential oils of copaiba- and andiroba against Leishmania infantum and Leishmania amazonensis infections.
    Dhorm Pimentel de Moraes AR; Tavares GD; Soares Rocha FJ; de Paula E; Giorgio S
    Exp Parasitol; 2018 Apr; 187():12-21. PubMed ID: 29518448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective effects of Euterpe oleracea (açai) on Leishmania (Leishmania) amazonensis and Leishmania infantum.
    Da Silva BJM; Souza-Monteiro JR; Rogez H; Crespo-López ME; Do Nascimento JLM; Silva EO
    Biomed Pharmacother; 2018 Jan; 97():1613-1621. PubMed ID: 29793323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3-Bis(aryloxy)propan-2-ols as potential antileishmanial agents.
    Lavorato SN; Duarte MC; Lage DP; Tavares CAP; Coelho EAF; Alves RJ
    Chem Biol Drug Des; 2017 Nov; 90(5):981-986. PubMed ID: 28590516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids.
    Aguilera E; Perdomo C; Espindola A; Corvo I; Faral-Tello P; Robello C; Serna E; Benítez F; Riveros R; Torres S; Vera de Bilbao NI; Yaluff G; Alvarez G
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis.
    Ramos GS; Vallejos VMR; Ladeira MS; Reis PG; Souza DM; Machado YA; Ladeira LO; Pinheiro MBV; Melo MN; Fujiwara RT; Frézard F
    Biomed Pharmacother; 2021 Feb; 134():111120. PubMed ID: 33341671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
    Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies.
    da Trindade Granato J; Dos Santos JA; Calixto SL; Prado da Silva N; da Silva Martins J; da Silva AD; Coimbra ES
    Biomed Pharmacother; 2018 Oct; 106():1082-1090. PubMed ID: 30119174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of the antileishmanial activity of silver compounds containing imidazolidine-2-thione.
    Espuri PF; Dos Reis LL; de Figueiredo Peloso E; Gontijo VS; Colombo FA; Nunes JB; de Oliveira CE; De Almeida ET; Silva DES; Bortoletto J; Segura DF; Netto AVG; Marques MJ
    J Biol Inorg Chem; 2019 May; 24(3):419-432. PubMed ID: 30949838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl-arylsulfonamides.
    da Silva LE; Joussef AC; Pacheco LK; da Silva DG; Steindel M; Rebelo RA; Schmidt B
    Bioorg Med Chem; 2007 Dec; 15(24):7553-60. PubMed ID: 17889546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and preliminary evaluation of new ursolic and oleanolic acids derivatives as antileishmanial agents.
    Gnoatto SC; Dalla Vechia L; Lencina CL; Dassonville-Klimpt A; Da Nascimento S; Mossalayi D; Guillon J; Gosmann G; Sonnet P
    J Enzyme Inhib Med Chem; 2008 Oct; 23(5):604-10. PubMed ID: 18608757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileishmanial Activity of Ezetimibe: Inhibition of Sterol Biosynthesis, In Vitro Synergy with Azoles, and Efficacy in Experimental Cutaneous Leishmaniasis.
    Andrade-Neto VV; Cunha-Júnior EF; Canto-Cavalheiro MM; Atella GC; Fernandes TA; Costa PR; Torres-Santos EC
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6844-6852. PubMed ID: 27600041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species.
    de Morais-Teixeira E; Gallupo MK; Rodrigues LF; Romanha AJ; Rabello A
    J Antimicrob Chemother; 2014 Jan; 69(1):150-4. PubMed ID: 23970484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmanicidal activity of Piper marginatum Jacq. from Santarém-PA against Leishmania amazonensis.
    Macêdo CG; Fonseca MYN; Caldeira AD; Castro SP; Pacienza-Lima W; Borsodi MPG; Sartoratto A; da Silva MN; Salgado CG; Rossi-Bergmann B; Castro KCF
    Exp Parasitol; 2020 Mar; 210():107847. PubMed ID: 32004535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential oil from Chenopodium ambrosioides and main components: activity against Leishmania, their mitochondria and other microorganisms.
    Monzote L; García M; Pastor J; Gil L; Scull R; Maes L; Cos P; Gille L
    Exp Parasitol; 2014 Jan; 136():20-6. PubMed ID: 24184772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.